- Home
- BPOP vs ALGN Comparison
BPOP vs ALGN Comparison
Compare BPOP & ALGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BPOP | ALGN |
|---|---|---|
| Founded | 1893 | 1997 |
| Country | United States | United States |
| Employees | 37 | N/A |
| Industry | Major Banks | Industrial Specialties |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.3B | 10.5B |
| IPO Year | 1999 | 2000 |
Fundamental Metrics
Financial Performance| Metric | BPOP | ALGN |
|---|---|---|
| Price | $159.09 | $154.14 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 10 | 16 |
| Target Price | ★ $195.20 | $193.79 |
| AVG Volume (30 Days) | 413.1K | ★ 836.1K |
| Earning Date | 10-22-2026 | 10-28-2026 |
| Dividend Yield | ★ 2.28% | N/A |
| EPS Growth | ★ 43.69 | 0.53 |
| EPS | ★ 8.13 | 3.09 |
| Revenue | ★ $756,100,000.00 | $387,126,000.00 |
| Revenue This Year | $8.13 | $2.95 |
| Revenue Next Year | $3.73 | $3.76 |
| P/E Ratio | ★ $19.36 | $50.30 |
| Revenue Growth | 16.00 | ★ 23.95 |
| 52 Week Low | $108.74 | $130.23 |
| 52 Week High | $179.24 | $200.44 |
Technical Indicators
Market Signals| Indicator | BPOP | ALGN |
|---|---|---|
| Relative Strength Index (RSI) | 48.94 | 59.62 |
| Support Level | $158.01 | $153.21 |
| Resistance Level | $160.06 | $162.92 |
| Average True Range (ATR) | 3.06 | 3.74 |
| MACD | 0.73 | 1.92 |
| Stochastic Oscillator | 63.53 | 90.33 |
Price Performance
Historical ComparisonAbout BPOP Popular Inc.
Popular Inc, based in Puerto Rico, is a financial holding company with four main subsidiaries: Banco Popular de Puerto Rico, a bank in Puerto Rico in terms of assets; Banco Popular North America, its banking operation in the continental United States; Evertec, a data processor; and Popular Financial Holdings, a diversified financial services company. The Corporation's reportable segments consist of Banco Popular de Puerto Rico and Popular U.S.
About ALGN Align Technology Inc.
Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.